WO2016159493A1 - Structure d'implant biodégradable - Google Patents

Structure d'implant biodégradable Download PDF

Info

Publication number
WO2016159493A1
WO2016159493A1 PCT/KR2016/000037 KR2016000037W WO2016159493A1 WO 2016159493 A1 WO2016159493 A1 WO 2016159493A1 KR 2016000037 W KR2016000037 W KR 2016000037W WO 2016159493 A1 WO2016159493 A1 WO 2016159493A1
Authority
WO
WIPO (PCT)
Prior art keywords
plate
marker
biodegradable
implant structure
screw
Prior art date
Application number
PCT/KR2016/000037
Other languages
English (en)
Korean (ko)
Inventor
이재춘
Original Assignee
(주)웹스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020150045352A external-priority patent/KR101538620B1/ko
Priority claimed from KR1020150045341A external-priority patent/KR101569698B1/ko
Application filed by (주)웹스 filed Critical (주)웹스
Publication of WO2016159493A1 publication Critical patent/WO2016159493A1/fr

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body

Definitions

  • the present invention relates to a biodegradable implant structure, and more particularly, to a biodegradable implant structure in which a bioabsorbable metal marker is inserted into a plate and a screw made of a biodegradable polymer to improve the mechanical strength of the structure and simultaneously observe the radiation.
  • a biodegradable implant structure in which a bioabsorbable metal marker is inserted into a plate and a screw made of a biodegradable polymer to improve the mechanical strength of the structure and simultaneously observe the radiation.
  • Representative materials for implants that are generally used for medical treatment are metal materials with excellent mechanical properties and processability. However, despite the excellent properties of metals, there are some problems, such as stress shielding, image degradation, implant migration, and the like.
  • biodegradable implants In order to overcome such drawbacks of metallic implants, research and development of biodegradable implants has been proposed. Medical applications of such biodegradable materials have been studied mainly from polymers such as polylactic acid (PLA), polyglycolic acid (PGA), or copolymers thereof.
  • PLA polylactic acid
  • PGA polyglycolic acid
  • biodegradable polymers have been limited in application due to low mechanical strength, acid generation problem during decomposition, difficulty in controlling biodegradation rate, and the like. My application in dental implants was difficult.
  • biomaterials that are mainly used as an implantable medical device are largely classified into metals, ceramics, and polymers, and require requirements such as strength, elastic modulus, durability, biostability, and ease of processing.
  • Table 1 is a table showing the compressive strength of the biomaterial to be the basis of strength, durability among the main factors.
  • metal materials such as titanium (Ti) and ceramic materials such as Hydroxyapatite (HA) show good effects in early bone union with high strength, but have high elastic modulus and high stress shielding effect. ) causes osteoporosis or destruction of surrounding bones, and foreign body reaction in vivo due to corrosion and ionization. In addition, most metal materials interfere with the strong magnetism of MRI, making it difficult to track and observe after the procedure.
  • Ti titanium
  • HA Hydroxyapatite
  • ceramic materials such as HA and bioglass have excellent biocompatibility and good compressive strength, but they are brittle and brittle and are very difficult to process. It has been used a lot of polymer material, PEEK, which has a compressive strength to fit and significantly improves its adaptability with the human body.
  • the PEEK has excellent strength, toughness and chemical stability, and has X-ray permeability.
  • the glass transition temperature is around 145 degrees, and the melting point is about 330-350 degrees, which is relatively stable to processing heat compared to other polymers.
  • the present invention has been made to solve the above problems, and an object of the present invention is to provide a biodegradable implant structure in which a bioabsorbable metal marker is inserted into a plate and a screw made of a biodegradable polymer.
  • an object of the present invention is to provide a biodegradable implant structure in which a bioabsorbable metal marker is inserted into a plate and a screw made of a biodegradable polymer to improve the strength and durability of the structure.
  • a biodegradable implant structure comprising: a plate formed of a biodegradable resin; A fastening hole penetrating through the plate; A screw inserted into the fastening hole; And a first marker formed of a bioabsorbable metal inside the plate.
  • the biodegradable implant structure of the present invention provides a structure in which a bioabsorbable metal and a biodegradable polymer are combined to improve mechanical strength and impact resistance, and to enable the observation of radiation (X-ray, etc.) observation. It is effective.
  • biodegradable implant structure of the present invention has the effect of providing a biodegradable implant structure that can be applied in a variety of applications, such as orthopedic, dental, cosmetic surgery.
  • biodegradable implant structure of the present invention has the effect of controlling the pH in the body by buffering the pH decrease or increase phenomenon caused by the decomposition of the bioabsorbable metal or biodegradable polymer.
  • FIG. 1 is a view showing a biodegradable implant structure according to an embodiment of the present invention.
  • FIG. 2 is a view showing a plate of a biodegradable implant structure according to the first embodiment of the present invention.
  • FIG 3 is a view showing a plate of the biodegradable implant structure according to the second embodiment of the present invention.
  • FIG. 4 is a view showing a plate of the biodegradable implant structure according to the third embodiment of the present invention.
  • FIG. 5 is a view showing a plate of the biodegradable implant structure according to the fourth embodiment of the present invention.
  • FIG. 6 is a view showing a plate of the biodegradable implant structure according to the fifth embodiment of the present invention.
  • FIG. 7 is a view showing a screw of the biodegradable implant structure according to an embodiment of the present invention.
  • FIG. 8 is a view showing various shapes of the biodegradable implant structure according to another embodiment of the present invention.
  • metals, bioabsorbable metals or biodegradable polymers used in conventional implant materials have the problems shown in Table 2 below.
  • the biodegradable implant structure of the present invention is a biodegradable implant structure configured by inserting a bioabsorbable metal reinforcing material into a biodegradable polymer to solve the above problems.
  • the biodegradable implant structure includes a plate 10 as a body, a fastening hole 20 formed through the plate 10, and a first marker 30 inserted into the plate. It is configured to include a screw 40 is inserted into the fastening hole 20.
  • the biodegradable implant structure according to the present invention is provided with a plate 10.
  • the plate 10 is a body of a biodegradable implant structure, and serves to connect bones.
  • the plate 10 is generally designed in a plate shape, as shown in FIG.
  • the plate 10 is composed of a biodegradable polymer.
  • the biodegradable polymer includes at least one of polylactic acid (PLA), polyglycolic acid (PGA), polylactic acid-glycolic acid copolymer (Polylactide-co-Glycolide, PLGA).
  • polylactic acid polyglycolic acid
  • PGA polyglycolic acid
  • FDA US Food and Drug Administration
  • the biodegradable implant structure according to the present invention is provided with a fastening hole 20 formed through the plate 10.
  • the fastening hole 20 is provided with a space for the screw 40 to be described later to penetrate the plate 10, by inserting the screw 40 so that the plate 10 and the bone is fixed do.
  • the number and shape of the fastening holes 20 may be variously designed such as circular, triangular, square, etc., according to the size and shape of the plate 10 and the screw 40. you can change it.
  • the biodegradable implant structure according to the present invention is provided with a first marker 30 inside the plate 10.
  • the first marker 30 serves to enhance the durability of the plate 10 and to enable radiation observation.
  • the first marker 30 is composed of at least one of a metal and a metal alloy.
  • the first marker 30 is composed of a metal or a metal alloy to improve the mechanical strength of the prosthetic material.
  • the first marker 30 is made of a bioabsorbable metal, it is possible to decompose in vivo to prevent side effects such as secondary removal surgery, an inflammatory reaction, and the like that occur after the progression of bone fusion during normal metal insertion.
  • the bioabsorbable metal used in the first marker 30 includes at least one metal or metal alloy of magnesium, calcium, manganese, iron, zinc, silicon, yttrium, zirconium, and gadolinium.
  • the biodegradable implant structure of the present invention is most preferably using magnesium or magnesium alloy as the bioabsorbable metal.
  • Magnesium is an inorganic component constituting the human body has no advantages in vivo, has a high strength and biodegradability, light weight and excellent processability.
  • the elastic modulus of magnesium is significantly lower than other medical metal materials, there is an advantage to prevent the stress shielding phenomenon, which is one of the failure factors of the metal prosthetics, implants.
  • the first marker 30 is made of a metal or a metal alloy, not only the mechanical strength is improved, but also the metal is inserted into the first marker 30 to enable the radiation observation tracking.
  • the first marker 30 made of metal is inserted into the plate 10 to enable radiation observation.
  • the first marker 30 serves as a criterion for determining whether the position of the plate 10 is correctly positioned through the observation of radiation.
  • the first marker 30 preferably has a shape such as a linear shape, a plate shape, a column shape, or the like so as to identify a position.
  • the first marker 30 is a linear shape extending in the longitudinal direction of the plate 10, a plate shape formed along the longitudinal direction of the plate, is formed in a direction perpendicular to the plate 10 It is composed of at least one of the columnar shape.
  • the first marker 30 is provided in a linear shape.
  • the first marker 30 is provided in a linear shape, so that the insertion position and the equilibrium of the implant structure can be confirmed.
  • the first marker 30 provided in the linear shape is preferably provided in two or more linear so as to more accurately observe the position and equilibrium when the radiation is observed.
  • the plate 10 may be provided in various shapes such as a curved line and a curved line.
  • the first marker 30 is provided in a plate shape.
  • the first marker 30 is provided in a plate shape along the longitudinal direction of the plate 10, so that the position and equilibrium of the inserted implant structure can be confirmed.
  • the first marker 30 is provided by combining horizontal and vertical line shapes along the length direction of the plate 10.
  • the first marker 30 is formed to cross the horizontal and vertical lines in the plate 10, the position and the equilibrium can be confirmed in the horizontal direction, to improve the durability by reinforcing the plate 10 Make it work.
  • the first marker 30 is provided in a vertical column shape with respect to the side surface of the plate 10 to support both ends of the plate 10. It is provided in the form of reinforcement.
  • the above and the fourth embodiment may be variously designed and modified as long as it can perform the reinforcement role in the vertical direction such as the cylindrical shape of (H) or the cylindrical shape including the hollow part (I) as shown in FIG. Check the insertion position and equilibrium.
  • the first marker 30 is provided in the horizontal direction and the vertical direction in combination to support and reinforce the plate 10 and at the same time the contact surface with the plate 10. By widening the stress distribution applied to the plate 10 and the first marker 30 can be made smoothly.
  • the first marker 30 is attached to the upper and lower surfaces of the plate 10, and the outer surface which is in contact with the exposure of the first marker 30 due to the decomposition of the plate 10. By widening the contact surface with, the stress applied to the contact surface can be dispersed.
  • the biodegradable polymer constituting the plate 10 has a sharp drop in strength may cause durability problems. This, by inserting the first marker 30 in the mold portion 10 to reinforce the body plate 10 to improve the durability, mechanical strength.
  • the first marker 30 is inserted into the plate 10 as described above. This structure has the effect of slowing down the decomposition rate of the fast absorbing bioabsorbable metal.
  • the bioabsorbable metal has a very rapid corrosion and decomposition rate, so that when exposed to the outside, the bioabsorbable metal decomposes faster than the plate 10, so that it is difficult to perform a role of reinforcing the plate 10.
  • the plate 10 made of a biodegradable polymer encapsulates the first marker 30 to protect from the outside has the effect of slowing down the decomposition rate of the bioabsorbable metal.
  • the acid generated from the biodegradable polymer when the plate 10 is decomposed and the base generated from the bioabsorbable metal of the first marker 30 is combined and neutralized.
  • the bioabsorbable metal generates various problems such as the generation of a large amount of hydrogen due to the decomposition reaction, the inflammation caused by the increase in pH, and the necrosis of surrounding tissues.
  • biodegradable polymers may cause a large amount of acid during the decomposition reaction to cause harmful effects on the human body.
  • the biodegradable implant structure according to the present invention is provided with a screw 40.
  • the screw 40 is inserted into the fastening hole 20 and coupled to the plate 10.
  • the screw 40 is inserted into the fastening hole 20 and is inserted and fixed to the spine, and serves to fix the biodegradable implant structure and the spine of the present invention, it is made of a biodegradable polymer.
  • the screw 40 has a variety of three-dimensional structures, such as rod-shaped, disc-shaped, and polyhedral, and is designed in various ways depending on the size and shape between the fastening hole 20 of the plate 10 and the spine into which the structure is inserted. you can change it.
  • the screw 40 may further include a second marker 50.
  • the second marker 50 is embedded in the screw 40 in a longitudinal line shape, thereby enabling radiological observation of the screw 40.
  • the second marker 50 embedded in the screw 40 may be observed with radiation to confirm whether the insertion position of the screw 40 inserted into the spine is correct.
  • the position of the second marker 50 can be varied in design according to the purpose of use of the implant structure, as shown in Figure 8 if it can perform a radiological observation role in the screw (40).
  • the biodegradable implant structure according to the present invention may further include a through hole 60 into which the device can be inserted based on the upper surface of the plate 10.
  • the through hole 60 penetrates through the plate 10 and serves to insert a medical device into the structure.
  • the position, size, shape, etc. of the through hole 60 may be changed in design depending on the position at which the implant is inserted and the purpose of the implant structure.
  • the biodegradable implant structure basically installs the plate 10 in the bone. At this time, the plate 10 serves as a body of the implant structure.
  • the biodegradable implant structure is installed by inserting the screw 40 in the fastening hole 20 of the plate 10, it is fixed by fastening it. At this time, the screw 40 is inserted into the fastening hole 20 and inserted into the bone to fix the bone and the implant structure.
  • the first marker 30 inserted into the plate 10 and the second marker inserted into the screw 40 ( 50) is observed to confirm the insertion position and equilibrium of the implant structure.
  • the plate 10 and the screw 40 are disassembled.
  • the first marker 30 and the second marker 50 are inserted into the plate 10 and the screw 40, respectively, and are not exposed to the outside so that no decomposition (absorption) reaction occurs.
  • the new bone grows and connects to the location where the decomposition proceeds.
  • the first and second markers 30 and 50 which are inserted into the plate 10 and the screw 40, are inserted into the plate 10 and the screw 40. Exposure occurs.
  • the plate 10 and the screw 40 may be disassembled, and at the same time, the biomarker of the first marker 30 and the second marker 50 may be removed. Decomposition (absorption) proceeds.
  • the screw 40, the first marker 30, and the second marker 50 are completely disassembled, no foreign matter remains in the place where the implant structure is located, and bones are connected.

Abstract

L'invention concerne une structure d'implant biodégradable et, plus particulièrement, une structure d'implant biodégradable dans laquelle un marqueur métallique bioabsorbable est installé par insertion dans une vis, et une plaque formée d'un polymère biodégradable de telle sorte que la résistance mécanique de la structure est améliorée, et que simultanément, une observation de rayonnement peut être effectuée.
PCT/KR2016/000037 2015-03-31 2016-01-05 Structure d'implant biodégradable WO2016159493A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR10-2015-0045352 2015-03-31
KR1020150045352A KR101538620B1 (ko) 2015-03-31 2015-03-31 생분해성 추간체 유합 보형재
KR1020150045341A KR101569698B1 (ko) 2015-03-31 2015-03-31 생분해성 임플란트 구조체
KR10-2015-0045341 2015-03-31

Publications (1)

Publication Number Publication Date
WO2016159493A1 true WO2016159493A1 (fr) 2016-10-06

Family

ID=57005155

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2016/000037 WO2016159493A1 (fr) 2015-03-31 2016-01-05 Structure d'implant biodégradable

Country Status (1)

Country Link
WO (1) WO2016159493A1 (fr)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050109915A (ko) * 2002-12-02 2005-11-22 마티스 메디지날테크닉 아게 뼈 고정용 임플란트
KR20080085139A (ko) * 2005-12-21 2008-09-23 신세스 게엠바하 스크류 보유 메커니즘을 가진 재흡수성 전방 경부 플레이팅시스템
KR20090099670A (ko) * 2008-03-18 2009-09-23 유앤아이 주식회사 생체분해성 마그네슘계 합금으로 다공성 구조체의 기공이충진된 복합재 임플란트 및 이의 제조방법
KR20100116566A (ko) * 2009-04-22 2010-11-01 유앤아이 주식회사 생체분해성 임플란트 및 이의 제조방법
KR20130139831A (ko) * 2010-07-09 2013-12-23 신세스 게엠바하 용이한 임플라트 제거를 위한 셀프 분리층
KR101569698B1 (ko) * 2015-03-31 2015-11-17 (주) 웹스 생분해성 임플란트 구조체

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050109915A (ko) * 2002-12-02 2005-11-22 마티스 메디지날테크닉 아게 뼈 고정용 임플란트
KR20080085139A (ko) * 2005-12-21 2008-09-23 신세스 게엠바하 스크류 보유 메커니즘을 가진 재흡수성 전방 경부 플레이팅시스템
KR20090099670A (ko) * 2008-03-18 2009-09-23 유앤아이 주식회사 생체분해성 마그네슘계 합금으로 다공성 구조체의 기공이충진된 복합재 임플란트 및 이의 제조방법
KR20100116566A (ko) * 2009-04-22 2010-11-01 유앤아이 주식회사 생체분해성 임플란트 및 이의 제조방법
KR20130139831A (ko) * 2010-07-09 2013-12-23 신세스 게엠바하 용이한 임플라트 제거를 위한 셀프 분리층
KR101569698B1 (ko) * 2015-03-31 2015-11-17 (주) 웹스 생분해성 임플란트 구조체

Similar Documents

Publication Publication Date Title
Nieminen et al. Amorphous and crystalline polyetheretherketone: Mechanical properties and tissue reactions during a 3‐year follow‐up
KR101742017B1 (ko) 재흡수성이고 생체적합성인 섬유 유리 조성물과 이를 사용하는 방법
Uezono et al. Hydroxyapatite/collagen nanocomposite‐coated titanium rod for achieving rapid osseointegration onto bone surface
Hasegawa et al. In vivo evaluation of a porous hydroxyapatite/poly‐DL‐lactide composite for use as a bone substitute
WO1990012605A1 (fr) Composites biodegradables pour utilisation medicale interne
KR20070078078A (ko) 외과용 임플란트 및 그 제조 방법
Bottagisio et al. Animal models of orthopaedic infections. A review of rabbit models used to induce long bone bacterial infections
DE69812644T2 (de) Halbineinandergreifendes polymernetzwerk
WO2017155328A1 (fr) Procédé de production de membrane de matrice extracellulaire obtenue à partir de cartilage porcin biocompatible capable de réguler un taux de décomposition in vivo et des propriétés physiques, et composition pour prévenir une adhérence contenant une matrice extracellulaire obtenue à partir de cartilage porcin comme principe actif
EP2852417B1 (fr) Compositions de biocéramique résorbable de poly-4-hydroxybutyrate et leurs copolymères
WO2015167050A1 (fr) Membrane barrière pour implant
Shasteen et al. Biodegradable internal fixation plates enabled with X‐ray visibility by a radiopaque layer of β‐tricalcium phosphate and poly (lactic‐co‐glycolic acid)
KR20170056330A (ko) 생분해성 임플란트 구조체
Kruse et al. Plasma immersion ion‐implanted 3D‐printed PEEK bone implants: In vivo sheep study shows strong osseointegration
WO2016159493A1 (fr) Structure d'implant biodégradable
KR101569698B1 (ko) 생분해성 임플란트 구조체
WO2011090255A2 (fr) Composition de ciment osseux facilement injectable a base de calcium
Yamashima Cranioplasty with hydroxylapatite ceramic plates that can easily be trimmed during surgery: a preliminary report
Kelley et al. Totally resorbable high-strength composite material
Jukkala-Partio et al. Healing of subcapital femoral osteotomies fixed with self-reinforced poly-L-lactide screws: an experimental long-term study in sheep
WO2018079992A1 (fr) Matériau composite biodégradable médical comprenant un agent de renforcement céramique fibreux, et son procédé de production
WO2014208824A1 (fr) Procédé de production d'implant ayant un matériau actif immobilisé sur sa surface et implant produit par celui-ci
WO2011071289A2 (fr) Matière absorbable, et fixation d'implant et implant utilisant celle-ci
ES2317195T3 (es) Sustrato implantable bioabsorbible.
Szponder et al. Use of calcium sulfate as a biomaterial in the treatment of bone fractures in rabbits–preliminary studies

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16773274

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205N DATED 07.12.2017)

122 Ep: pct application non-entry in european phase

Ref document number: 16773274

Country of ref document: EP

Kind code of ref document: A1